About this trial
Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Age between 18 and 50 years old
PHQ-9 score between 10 and 19 (moderate depression)
Availability for sessions
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Auricular Acupuncture
DeviceAplication of semi-permanents needls in the ear by an experient and specialized professional using tradicional chinese maps and a specific device to find acupuncture points. There is a gap of one day minimum between sessions and two non-consecutive absences are allowed.
Treatment groups
Trial outcomes
Primary outcomes
Decrease of Depression Symptoms
The efficacy of auricular acupuncture to reduce depression symptoms compared to non-specific auricular acupuncture 3 months after study inclusion.
Secondary outcomes
BDNF, Interleukin, TNF
Levels of BDNF, Interleukin 1β, Interleukin-6 and TNF-α, evaluated at the beginning and end of auricular acupuncture applications (end of the sixth week of application)
Decrease of Depression Symptoms
The efficacy of auricular acupuncture to reduce depression symptoms compared to non-specific auricular acupuncture 6 weeks after study inclusion.
Decrease of Depression Symptoms
The efficacy of auricular acupuncture to reduce depression symptoms compared to non-specific auricular acupuncture 6 months after study inclusion.
Decrease of Depression Symptoms
The efficacy of auricular acupuncture to reduce depression symptoms compared to non-specific auricular acupuncture 4 weeks after study inclusion.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Universidade do Sul de Santa Catarina
Lead sponsor
University of Sao Paulo
Collaborator